Edition:
United Kingdom

Cellectis SA (ALCLS.PA)

ALCLS.PA on Paris Stock Exchange

17.55EUR
18 Apr 2019
Change (% chg)

€0.20 (+1.15%)
Prev Close
€17.35
Open
€17.47
Day's High
€17.59
Day's Low
€17.28
Volume
34,311
Avg. Vol
63,023
52-wk High
€27.26
52-wk Low
€13.51

About

Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development and commercialization of rational genome engineering technologies. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid... (more)

Overall

Beta: 1.09
Market Cap(Mil.): €864.14
Shares Outstanding(Mil.): 35.42
Dividend: --
Yield (%): --

Financials

  ALCLS.PA Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -1.91 -- --
ROI: -27.62 8.91 13.83
ROE: -27.69 10.06 15.25

BRIEF-Cellectis Q4 Operating Loss Widens To 29.3 Million Dollars

* ANNOUNCED ON MONDAY, CELLECTIS REPORTS 4TH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS

12 Mar 2019

BRIEF-Cellectis Reports End-Sept Cash Of 475.9 Million Dollars

* REPORTED ON TUESDAY TOTAL CASH, CASH EQUIVALENTS AND CURRENT FINANCIAL ASSETS $475.9 MILLION AS OF SEPTEMBER 30, 2018

14 Nov 2018

Earnings vs. Estimates